Federal News & Issues

Washington, D.C., Oct. 2, 2020 -The American Psychiatric Association (APA) today applauded the mental health and addiction-related resources included in the Heroes Act (H.R. 8406) passed by the U.S. House.  Evidence is mounting that the COVID-19 pandemic is exacerbating mental health conditions, while the economic consequences of the pandemic have been reducing the mental health and substance use treatment capacity across the country. The resources in the House-passed Heroes Act constitute a needed step toward treatment for mental illness and substance use disorders. The bill includes: 

• $8.5 billion for the Substance Abuse and Mental Health Services Administration to fund state mental health and substance abuse block grants, trauma-informed care and other services and supports for schoolchildren, suicide prevention and...

WASHINGTON, D.C., September 15, 2020 – The American Psychiatric Association Foundation (APAF), the philanthropic and educational arm of APA, joins a new public-private partnership launched today by the National Institute of Health (NIH) that is aimed at meeting the urgent need for early therapeutic interventions for people at risk of developing schizophrenia. It is part of the Accelerating Medicines Partnership (AMP) that promotes development of effective, targeted treatments.

AMP Schizophrenia brings together NIH, the Food and Drug Administration and multiple non-profit and private organizations. These partners will work to discover promising biological markers that can help identify people at risk of developing schizophrenia as early...